Neuralink raises $280 million in Series D round led by Founders Fund
Portfolio company Neuralink, Elon Musk's brain-chip startup, secures pre-IPO funding of $280 million, boosting its valuation to $5 billion.
Led by Founders Fund, this move amplifies investor confidence and elevates IPO prospects as Neuralink ventures deeper into AI-driven medical breakthroughs.
In a significant pre-IPO move, Neuralink, the brain-chip startup co-founded by industry giant Elon Musk, has successfully clinched a funding round of $280 million. This comes in the wake of the company's recent FDA clearance for trials of their innovative brain chips in humans. With this new capital infusion, the stock's potential is making waves as Neuralink's valuation now sits at an impressive $5 billion.
For more coverage about Neuralink stock, subscribe to our club letter
The Series D funding was championed by Founders Fund, a venture capital powerhouse co-founded by Peter Thiel. For those closely following stock movements and IPO buzz, Thiel's name might ring a bell. He has previously invested in other groundbreaking ventures linked to Musk, such as SpaceX and The Boring Company. Notably, this isn't Founders Fund's maiden venture with Neuralink; they had earlier marked their presence in a Series C round for the company.
While the company remains tight-lipped about specific deployment plans for the raised funds, hints were dropped by both Neuralink and Scott Nolan, a partner at Founders Fund. Both parties highlighted the company’s career page, signaling the possibility of significant team expansion.
Investors seeking to capitalize on Neuralink's promising trajectory can now seize the opportunity through IPO CLUB, the premier pre-IPO platform. Catering exclusively to accredited, qualified, and institutional investors, IPO CLUB offers a streamlined avenue to invest in trailblazing companies like Neuralink before they go public.
Please note: This information is for informational purposes only and should not be considered financial advice.
